Weinreich T, Rambausek M, Ritz E
Department of Internal Medicine, University of Heidelberg, Germany.
Nephrol Dial Transplant. 1991;6(11):843-5. doi: 10.1093/ndt/6.11.843.
Progression of hyperparathyroidism and bone disease on CAPD has been noted by several authors. In our CAPD patients we observed that aluminium-containing phosphate binders were often required because administration of CaCO3 was limited by the development of hypercalcaemia particularly in patients concomitantly requiring calcitriol. We propose that CAPD fluids with lower calcium concentration should be evaluated to facilitate control of plasma phosphate and secondary hyperparathyroidism.
几位作者已经注意到持续性非卧床腹膜透析（CAPD）患者甲状旁腺功能亢进和骨病的进展。在我们的CAPD患者中，我们观察到，由于碳酸钙的使用受到高钙血症发展的限制，特别是在同时需要骨化三醇的患者中，通常需要使用含铝的磷酸盐结合剂。我们建议，应评估钙浓度较低的CAPD透析液，以促进血浆磷酸盐的控制和继发性甲状旁腺功能亢进。
